Last update 04 Nov 2024

Amlodipine Besylate/Olmesartan Medoxomil

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Azor, Ol-Vamlo, Olmersartan medoxomil/amlodipine besilate
+ [6]
Mechanism
AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), VDCCs blockers(Voltage-gated calcium channel blockers)
Therapeutic Areas
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (26 Sep 2007),
Regulation-
Login to view timeline

Structure

Molecular FormulaC29H30N6O6
InChIKeyUQGKUQLKSCSZGY-UHFFFAOYSA-N
CAS Registry144689-63-4
View All Structures (2)

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Essential Hypertension
CN
12 Jul 2018
Hypertension
US
26 Sep 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
2,204
Olmesartan(OLM)
(Olmesartan(OLM) 40 Mg-Amlodipine(AML) 10 mg)
xsnzzswtwu(fxybmidrwm) = najubilvtb jstuacryux (qmbapgfivu, kqdpxghrja - rwtmexpxzj)
-
22 Nov 2011
OLM 40+AML
(OLM 40-AML 10-Hydrochlorothiazide (HCTZ) 12.5)
xsnzzswtwu(fxybmidrwm) = lkdddfqyqe jstuacryux (qmbapgfivu, wmkfjjbbog - xzatdiztih)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free